{"filing":{"accession_number":"0001683168-26-007951","cik":"0001160420","ticker":"ADIA","company_name":"Adia Med, Inc.","form":"8-K","filing_date":"2026-10-19","report_date":"2026-10-13","primary_document":"adia_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1160420/000168316826007951/adia_8k.htm"},"events":[{"id":36025,"run_id":33213,"accession_number":"0001683168-26-007951","anchor_item_number":"1.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.75,"summary":"The Company entered into a Membership Interest Purchase Agreement on October 13, 2026, selling seven percent (7%) membership interest units in Adia Labs LLC to CEO Larry A. Powalisz for $350,000. This constitutes a material disposition of equity interests in a subsidiary entity, fitting the definition of M\u0026A activity under Item 1.01. The transaction involves a related-party sale with governance safeguards (independent director approval of proceeds use), indicating materiality to investors assessing control and capital allocation.","company_name":"Adia Med, Inc.","ticker":"ADIA","filing_date":"2026-10-19","form":"8-K","submitted_at":null,"items":[{"id":40295,"accession_number":"0001683168-26-007951","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"The Company entered into a Membership Interest Purchase Agreement on October 13, 2026, selling seven percent (7%) membership interest units in Adia Labs LLC to CEO Larry A. Powalisz for $350,000. This constitutes a material disposition of equity interests in a subsidiary entity, fitting the definition of M\u0026A activity under Item 1.01. The transaction involves a related-party sale with governance safeguards (independent director approval of proceeds use), indicating materiality to investors assessing control and capital allocation.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-19T15:23:36.853932+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":40295,"accession_number":"0001683168-26-007951","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"The Company entered into a Membership Interest Purchase Agreement on October 13, 2026, selling seven percent (7%) membership interest units in Adia Labs LLC to CEO Larry A. Powalisz for $350,000. This constitutes a material disposition of equity interests in a subsidiary entity, fitting the definition of M\u0026A activity under Item 1.01. The transaction involves a related-party sale with governance safeguards (independent director approval of proceeds use), indicating materiality to investors assessing control and capital allocation.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-19T15:23:36.853932+00:00","company_name":"Adia Med, Inc.","ticker":"ADIA","filing_date":"2026-10-19"}]}